142 related articles for article (PubMed ID: 38267285)
1. Percutaneous left atrial appendage occlusion in mitral valve disease: A Nationwide Readmission Database analysis.
Feroze R; Ullah W; Kang P; Lobo T; Alhabdan N; Alghammass M; Yoon SH; Dallan LAP; Filby SJ
Cardiovasc Revasc Med; 2024 Jun; 63():23-30. PubMed ID: 38267285
[TBL] [Abstract][Full Text] [Related]
2. Left Atrial Appendage Occlusion in Patients With Anticoagulation Failure vs Anticoagulation Contraindication.
Aarnink EW; Maarse M; Fierro N; Mazzone P; Beneduce A; Tondo C; Gasperetti A; Pracon R; Demkow M; Zieliński K; de Backer O; Korsholm K; Nielsen-Kudsk JE; Estévez-Loureiro R; Caneiro-Queija B; Benito-González T; Pérez de Prado A; Nombela-Franco L; Salinas P; Holmes D; Almakadma AH; Berti S; Romeo MR; Millan X; Arzamendi D; Alla VM; Agarwal H; Eitel I; Paitazoglou C; Freixa X; Cepas-Guillén P; Chothia R; Badejoko SO; Spoon DB; Maddux JT; El-Chami M; Ram P; Branca L; Adamo M; Suradi HS; Peper J; van Dijk VF; Rensing BJWM; Swaans MJ; Vireca E; Bergmann MW; Boersma LVA;
JACC Cardiovasc Interv; 2024 Jun; 17(11):1311-1321. PubMed ID: 38795093
[TBL] [Abstract][Full Text] [Related]
3. Percutaneous left atrial appendage occlusion: A review of current devices, clinical evidence, patient selection, and post procedural antithrombotic management.
Jackson LR; Jackson KP; Thomas KL
Prog Cardiovasc Dis; 2021; 66():92-100. PubMed ID: 34332665
[TBL] [Abstract][Full Text] [Related]
4. Association of atrial myopathy in mitral valve disease on safety outcomes in left atrial appendage closure.
Kany S; Skibowski J; Müller CH; Geist V; Schmitt J; Niroomand F; Hailer B; Pleger S; Akin I; Hochadel M; Senges J; Lubos E
Clin Res Cardiol; 2023 Jun; 112(6):824-833. PubMed ID: 36739561
[TBL] [Abstract][Full Text] [Related]
5. Outcomes and predictors of readmission after implantation of a percutaneous left atrial appendage occlusion device in the United States: A propensity score-matched analysis from The National Readmission Database.
Pasupula DK; Munir MB; Bhat AG; Siddappa Malleshappa SK; Meera SJ; Spooner M; Koranne K; Olshansky B; Hirji S; Hsu JC
J Cardiovasc Electrophysiol; 2021 Nov; 32(11):2961-2970. PubMed ID: 34535939
[TBL] [Abstract][Full Text] [Related]
6. Head-to-head comparison between left atrial appendage occlusion and non-vitamin K oral anticoagulants in non-valvular atrial fibrillation patients: A systematic review and meta-analysis study.
Waranugraha Y; Lin LY; Tsai CT
Trends Cardiovasc Med; 2024 May; 34(4):225-233. PubMed ID: 36775218
[TBL] [Abstract][Full Text] [Related]
7. Utilization and adverse outcomes of percutaneous left atrial appendage closure for stroke prevention in atrial fibrillation in the United States: influence of hospital volume.
Badheka AO; Chothani A; Mehta K; Patel NJ; Deshmukh A; Hoosien M; Shah N; Singh V; Grover P; Savani GT; Panaich SS; Rathod A; Patel N; Arora S; Bhalara V; Coffey JO; O'Neill W; Makkar R; Grines CL; Schreiber T; Di Biase L; Natale A; Viles-Gonzalez JF
Circ Arrhythm Electrophysiol; 2015 Feb; 8(1):42-8. PubMed ID: 25480543
[TBL] [Abstract][Full Text] [Related]
8. Left atrial appendage occlusion with the Amplatzer Cardiac Plug could improve survival and prevent thrombo-embolic and major bleeding events in atrial fibrillation patients with increased bleeding risk.
Budts W; Laenens D; Van Calenbergh F; Vermeersch P; De Potter T; Aminian A; Benit E; Stammen F; Kefer J
Acta Cardiol; 2016 Apr; 71(2):135-43. PubMed ID: 27090034
[TBL] [Abstract][Full Text] [Related]
9. Association Between Left Atrial Appendage Occlusion and Readmission for Thromboembolism Among Patients With Atrial Fibrillation Undergoing Concomitant Cardiac Surgery.
Friedman DJ; Piccini JP; Wang T; Zheng J; Malaisrie SC; Holmes DR; Suri RM; Mack MJ; Badhwar V; Jacobs JP; Gaca JG; Chow SC; Peterson ED; Brennan JM
JAMA; 2018 Jan; 319(4):365-374. PubMed ID: 29362794
[TBL] [Abstract][Full Text] [Related]
10. Unconventional combination of left atrial appendage device occlusion in patients with atrial fibrillation who needed concomitant catheter interventions for underlying structural heart disease.
Raghuram P; Pavithran S; Sivakumar K
Indian Heart J; 2020; 72(5):369-375. PubMed ID: 33189196
[TBL] [Abstract][Full Text] [Related]
11. Combined atrial fibrillation ablation and left atrial appendage occlusion procedure in the United States: a propensity score matched analysis from 2016-2019 national readmission database.
Pasupula DK; Siddappa Malleshappa SK; Munir MB; Bhat AG; Anandaraj A; Jakkoju A; Spooner M; Koranne K; Hsu JC; Olshansky B; Camm AJ
Europace; 2023 Feb; 25(2):390-399. PubMed ID: 36350997
[TBL] [Abstract][Full Text] [Related]
12. An under-recognized high-risk atrial fibrillation population: Analyzing transcatheter mitral valve repair patients for left atrial appendage closure device application.
Lane CE; Eleid MF; Holmes DR
Catheter Cardiovasc Interv; 2019 Aug; 94(2):274-279. PubMed ID: 30953408
[TBL] [Abstract][Full Text] [Related]
13. Propensity-Matched Comparison of Oral Anticoagulation Versus Antiplatelet Therapy After Left Atrial Appendage Closure With WATCHMAN.
Søndergaard L; Wong YH; Reddy VY; Boersma LVA; Bergmann MW; Doshi S; Kar S; Sievert H; Wehrenberg S; Stein K; Holmes DR
JACC Cardiovasc Interv; 2019 Jun; 12(11):1055-1063. PubMed ID: 31171282
[TBL] [Abstract][Full Text] [Related]
14. Thromboembolic events and need for anticoagulation therapy following left atrial appendage occlusion in patients with electrical isolation of the appendage.
Gadiyaram VK; Mohanty S; Gianni C; Trivedi C; Al-Ahmad A; Burkhardt DJ; Gallinghouse JG; Hranitzky PM; Horton RP; Sanchez JE; Della Rocca DG; Di Biase L; Price MJ; Couts L; Gibson D; Natale A
J Cardiovasc Electrophysiol; 2019 Apr; 30(4):511-516. PubMed ID: 30623500
[TBL] [Abstract][Full Text] [Related]
15. Operator Experience and Outcomes after Transcatheter Left Atrial Appendage Occlusion with the Watchman Device.
Sawant AC; Seibolt L; Sridhara S; Rodriguez J; Distler E; Murarka S; Lazkani M; Kumar A; Kanwar N; Prakash MPH; Wiesner P; Pershad A
Cardiovasc Revasc Med; 2020 Apr; 21(4):467-472. PubMed ID: 31501020
[TBL] [Abstract][Full Text] [Related]
16. Percutaneous left atrial appendage occlusion using different technologies in the United Kingdom: A multicenter registry.
Betts TR; Leo M; Panikker S; Kanagaratnam P; Koa-Wing M; Davies DW; Hildick-Smith D; Wynne DG; Ormerod O; Segal OR; Chow AW; Todd D; Cabrera Gomez S; Kirkwood GJ; Fox D; Pepper C; Foran J; Wong T
Catheter Cardiovasc Interv; 2017 Feb; 89(3):484-492. PubMed ID: 27651124
[TBL] [Abstract][Full Text] [Related]
17. Periprocedural Pericardial Effusion Complicating Transcatheter Left Atrial Appendage Occlusion: A Report From the NCDR LAAO Registry.
Price MJ; Valderrábano M; Zimmerman S; Friedman DJ; Kar S; Curtis JP; Masoudi FA; Freeman JV
Circ Cardiovasc Interv; 2022 May; 15(5):e011718. PubMed ID: 35369701
[TBL] [Abstract][Full Text] [Related]
18. Incidence and causes of in-hospital outcomes and 30-day readmissions after percutaneous left atrial appendage closure: A US nationwide retrospective cohort study using claims data.
Vuddanda VLK; Turagam MK; Umale NA; Shah Z; Lakkireddy DR; Bartus K; McCausland FR; Velagapudi P; Mansour M; Heist EK
Heart Rhythm; 2020 Mar; 17(3):374-382. PubMed ID: 31539630
[TBL] [Abstract][Full Text] [Related]
19. Patient-Level Analysis of Watchman Left Atrial Appendage Occlusion in Practice Versus Clinical Trials.
Friedman DJ; Du C; Wang Y; Agarwal V; Varosy PD; Masoudi FA; Holmes DR; Reddy VY; Price MJ; Curtis JP; Freeman JV
JACC Cardiovasc Interv; 2022 May; 15(9):950-961. PubMed ID: 35512918
[TBL] [Abstract][Full Text] [Related]
20. Outcomes and Readmissions after Left Atrial Appendage Occlusion in Octogenarians: A Contemporary Analysis.
Barsoum K; Khalil M; Eid MM; Hassib M; Ibrahim F; Khalife W; Chatila K; Pandey R; Abdou C; Bandyopadhyay D; Rai D; Aronow WS; Rangasetty UC
J Am Med Dir Assoc; 2024 Feb; 25(2):356.e1-356.e6. PubMed ID: 37634550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
